JPRN-UMIN000022563未知未知
The efficacy of paritaprevir and ombitasvir with a booster dose of ritonavir in genotype 1 HCV patients with hemodialysis - Viek-tory HD study
适应症
试验速览
- 阶段
- 未知
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients who are allergic to paritaprevir, ombitasvir, or ritonavir. 2) patients with decompensated cirrhosis (Child-Pugh Class B or C) 3) pregnant women and women suspected of being pregnant 4) patients ineligible for some other reasons
研究者
相似试验
尚未招募
不适用
Efficacy and safety of paritaprevir and ombitasvir in patients with chronic hepatitis CJPRN-UMIN000020019Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
招募中
不适用
Evaluation of the efficacy of ombitasvir and paritaprevir with ritonavir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000021276Toranomon Hospital100
已完成
不适用
Efficacy and Safety of Ombitasvir plus Paritaprevir/r combination regimen for Hepatitis C infected patients with immune disordersPatients with genotype 1 HCV infection who have immune disorderJPRN-UMIN000020302Hokkaido University50
招募中
不适用
Efficacy and safety of ombitasvir/paritaprevir/ritonavir, ledipasvir/sofosbuvir, elbasvir /grazoprevir, glecaprevir/pibrentasvir after curative treatment of HCV-Related HCC - Prospective multicenter-cooperative cohort studyHCV-related hepatocellular carcinomaJPRN-UMIN000025085Juntendo University Hospital80
已完成
不适用
Efficacy and safety of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000021123shonan kamakura general hospital100